Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      DefenAge Upgrades Its Iconic 8-in-1 BioSerum To A MEGA Size And Launches It As A Black Friday Special

      Most potent concentration of defensin-molecules makes skin look young again

      DefenAge Logo (PRNewsfoto/DefenAge)

      News provided by

      DefenAge

      Nov 27, 2020, 06:55 ET

      Share this article

      Share this article


      CARLSBAD, Calif., Nov. 27, 2020 /PRNewswire/ -- DefenAge® Skincare, the manufacturer and distributor of the revolutionary, evidence-based, anti-aging products, announces the launch of its highly anticipated MEGA SIZE of 8-in-1 BioSerum. DefenAge added .5 ounces to the standard size of its iconic bestseller and concept anti-aging cream, the 8-in-1 BioSerum, that launched the line and ignited a skincare revolution five years ago.

      Continue Reading
      DefenAge Launches MEGA SIZE of 8-in-1 BioSerum as Black Friday Special
      DefenAge Launches MEGA SIZE of 8-in-1 BioSerum as Black Friday Special

      "Patients really are the biggest judge. I have been in practice for about 21 years now and I've had all the in-office dispensed skin care lines. DefenAge by far has had the most impressive patient feedback of any new skincare line that we have offered," comments dermatologist Angela Bowers, MD, Founder of Southlake Dermatology, Southlake, TX.

      The 8-in-1 BioSerum is designed to instantly rejuvenate the skin's smoothness, radiance and hydration while minimizing the appearance of lines, wrinkles, age spots, redness and pore size, and visibly brightening skin.

      The core of the product's technology is DefenAge's proprietary Age-Repair Defensins® that are infused in the product at the highest daily concentration and backed by 7 clinical studies. "DefenAge wasn't just repackaging retinol or vitamin C or something else, rather using very intriguing immunological defensin-molecules that are some of the first line in our immune system defenses," said dermatologist Anne Chapas, MD, Director at Union Square Laser Dermatology in New York City, NY.

      "With defensins, you are getting a very specific portion of the antiaging process turned on and creating a younger and new-looking epidermis," explains dermatologist Amy Forman Taub, MD, Medical Director at Advanced Dermatology, Lincolnshire, IL, "DefenAge's iconic 8-in-1 BioSerum is an advanced targeted cosmetic treatment with an established scientific mechanism of action."

      A new-launch inaugural article accumulates experiences and recommendations of Key Opinion Leaders in dermatology and aesthetic medicine and is published on Dermatology Digest this month. "I recommend the 8-in-1 BioSerum, not only as a part of patients' daily skincare, but also to achieve optimal outcomes after procedures I do in the office, including microneedling," said dermatologist Vivian Bucay, MD, Bucay Center for Dermatology and Aesthetics, in San Antonio, TX. "I also feel confident that the patients will be less likely to break out with acne post treatment when I use the 8-in-1 BioSerum."

      Dr. Chapas recommends the 8-in-1 BioSerum "as a rejuvenation cosmetic serum for patients who want smoother pores, more skin firmness, or better overall skin quality. It is also a unisex product for both men and women." Dr. Bowers adds, "the 8-in-1 BioSerum doesn't tend to irritate the skin, all skin types tolerate it."

      "I have hundreds of patients who could not be happier with the dramatic changes they see with the 8-in-1 BioSerum on their face. Within a month they are asking if it can be used anywhere else. The first area I recommend is taking it down on the neck and décolleté. Anywhere it is applied, you start seeing fewer fine lines and more luminosity and clarity," comments dermatologist Steven Swengel, MD, Medical Director of RefinedMD, Los Gatos, CA."

      The MEGA size 8-in-1 BioSerum (1.5 fl oz | 45 ml) is available on www.defenage.com starting today. From Black Friday to Cyber Monday (November 27-30, 2020), the new MEGA size BioSerum will be available for the price of a standard-size 1 fl oz 8-in-1 BioSerum ($165 with a free account). You get 50% more product for the same price! After that, it will retail for $198.

      About DefenAge®:
      DefenAge is a technology-driven, evidence-based, luxury beauty brand, tested and recommended by dermatologists as a stand-alone, high-performing anti-aging cosmetic skincare and safe alternative for retinol for visible skin rejuvenation. DefenAge complies with or exceeds the Clean Beauty standards and its products have never been tested on animals. The line includes the advanced anti-aging cream, 3-piece comprehensive dermatologist recommended skin care regimen, award winning eye cream named the best eye cream for dark circles, neck tightening cream, skin brightening mask, luxurious face cleanser, and men's skincare kit.

      Dermatologist quotes used in this press release were originally published in the article, "Dermatologists Weigh in on DefenAge's 8-in-1 BioSerum: Patient Outcomes, Optimal Use" by Dermatology Digest.

      SOURCE DefenAge

      Modal title

      Also from this source

      DefenAge's 7X Calming Complex Wins NewBeauty Award for "Best Inflammaging Serum"

      DefenAge's 7X Calming Complex Wins NewBeauty Award for "Best Inflammaging Serum"

      DefenAge® Skincare proudly announces that its 7X Calming Complex, a targeted treatment designed to calm inflammation-driven skin aging, has been...

      DefenAge Skincare's 7X Calming Complex Named a 2026 People en Español Star Product

      DefenAge Skincare's 7X Calming Complex Named a 2026 People en Español Star Product

      DefenAge® Skincare's 7X Calming Complex has earned a coveted spot on People en Español's 2026 Star Products list, recognized for redefining how...

      More Releases From This Source

      Explore

      Retail

      Retail

      Household, Consumer & Cosmetics

      Household, Consumer & Cosmetics

      Cosmetics and Personal Care

      Cosmetics and Personal Care

      New Products & Services

      New Products & Services

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.